Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

Abstract Clustered regulatory interspaced short palindromic repeats (CRISPR) has changed biomedical research and provided entirely new models to analyze every aspect of biomedical sciences during the last decade. In the study of cancer, the CRISPR/CRISPR-associated protein (Cas) system opens new ave...

Full description

Bibliographic Details
Main Authors: Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, Hazha Jamal Hidayat, Goran Sedeeq Hama Faraj, Fattma Abodi Ali, Abbas Salihi, Aria Baniahmad, Soudeh Ghafouri-Fard, Milladur Rahman, Mark C. Glassy, Wojciech Branicki, Mohammad Taheri
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Military Medical Research
Subjects:
CRISPR
CRISPR/Cas9
CRISPR/Cas12
Gene editing
miRNAs
Cancer therapy
Online Access:https://doi.org/10.1186/s40779-023-00468-6

Internet

https://doi.org/10.1186/s40779-023-00468-6

Similar Items